There are 24 open roles in Massachusetts at companies that raised in the last 180 days, including 15 at Post-IPO Equity companies and 12 in operations.
Locations are printed exactly as each employer publishes them, so "Massachusetts" here folds together every spelling its careers feed uses. A round that closed weeks ago means new budget and a headcount plan written against it, which is why every card below leads with the round, the amount and how long ago the money landed. These careers feeds do not publish salary, so no salary is shown or estimated.
All 24 of them, most recently posted first.
Allara · Allara is a specialty care platform that offers a healthcare program for women's hormonal health and PCOS thro…
Massachusetts·8 days ago(remote)
Allara · Allara is a specialty care platform that offers a healthcare program for women's hormonal health and PCOS thro…
Massachusetts·8 days ago(remote)
Allara · Allara is a specialty care platform that offers a healthcare program for women's hormonal health and PCOS thro…
Massachusetts·9 days ago(remote)
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$127K–$156K·Massachusetts - Hybrid·10 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$222K–$272K·Massachusetts - Hybrid·14 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$293K–$358K·Massachusetts - Hybrid·15 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$174K–$212K·Massachusetts - Hybrid·23 days ago
Allara · Allara is a specialty care platform that offers a healthcare program for women's hormonal health and PCOS thro…
Massachusetts·27 days ago(remote)
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$96K–$118K·Massachusetts - Hybrid·28 days ago
Allara · Allara is a specialty care platform that offers a healthcare program for women's hormonal health and PCOS thro…
Massachusetts·36 days ago(remote)
Allara · Allara is a specialty care platform that offers a healthcare program for women's hormonal health and PCOS thro…
Massachusetts·36 days ago(remote)
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$173K–$212K·Massachusetts - Hybrid·37 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$207K–$253K·Massachusetts - Hybrid·42 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$261K–$319K·Massachusetts - Hybrid·43 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$261K–$319K·Massachusetts - Hybrid·43 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$151K–$185K·Massachusetts·50 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$187K–$228K·Massachusetts - Hybrid·52 days ago
Cresco Labs · Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the…
$55K–$60K·Massachusetts, MA·55 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$207K–$253K·Massachusetts - Hybrid·55 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$279K–$341K·Massachusetts - Hybrid·65 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$261K–$319K·Massachusetts - Hybrid·66 days ago
Disc Medicine · Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood d…
$173K–$212K·Massachusetts - Hybrid·78 days ago
Allara · Allara is a specialty care platform that offers a healthcare program for women's hormonal health and PCOS thro…
Massachusetts·87 days ago(remote)
Expressable · Expressable is an online speech therapy platform designed for individuals with communication disorders.
$40–$58/hr·Massachusetts·4 months ago(remote)
Members see them first, with an alert the moment a role hits.
Get Job Seeker — $49/yearEverything older is free on this board.
Counts are open roles inside the same 180-day funding window. Only cuts with at least 8 roles get a page.
There are 24 open roles in Massachusetts at companies that raised in the last 180 days, including 15 at Post-IPO Equity companies and 12 in operations. They sit across 4 companies, and the page lists the 24 most recently posted of them.
Every employer on this page closed its most recent funding round within the last 180 days. That is a hard cap: a company drops off the board the day its round passes 180 days old, which is why the counts on this page move week to week.
The employers with the most open roles on this page right now are Disc Medicine (15), Allara (7), Cresco Labs (1), Expressable (1). Each of them raised inside the last 180 days.
By round, the largest groups are Post-IPO Equity (15), Venture - Series Unknown (8), Post-IPO Debt (1). Round size is the single best proxy for how a company hires: earlier-stage teams hire generalists onto small teams, later-stage teams hire into an existing function with a defined scope.
No. The applicant tracking system feeds behind these roles do not publish salary bands, so no salary figure or estimate appears anywhere on this board. Each card shows the round, the amount raised, how long ago it closed, the lead investors and the team size instead.
It rebuilds from the database several times a day. The most recent round represented on the wider board closed on 2026-10-29, and the board currently carries 29,957 roles at 1,202 companies in total.